{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T17:25:55Z","timestamp":1774805155643,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates from community-acquired respiratory tract infections (CA-RTIs) collected in 2015\u201317 from Turkey.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 179 S. pneumoniae and 239 H. influenzae isolates were collected. Few (27.9%) pneumococci were penicillin susceptible by CLSI oral or EUCAST low-dose breakpoints, but by EUCAST high-dose or CLSI IV breakpoints 84.4% were susceptible. The most active antibiotics (excluding penicillin IV) by CLSI breakpoints were fluoroquinolones (98.9% of isolates susceptible), ceftriaxone (83.2%), amoxicillin (78.8%) and amoxicillin\/clavulanic acid (78.8%). Pneumococcal susceptibility to amoxicillin and amoxicillin\/clavulanic acid was lower using EUCAST low-dose breakpoints (49.7%), although susceptibility increased when using EUCAST high-dose (57.0%\u201358.1%) and PK\/PD (78.8%\u201387.7%) breakpoints. Twenty-three H. influenzae isolates were \u03b2-lactamase positive, with 11 characterized as \u03b2-lactamase negative and ampicillin resistant following EUCAST criteria and 5 by CLSI criteria. Generally antibiotic susceptibility was high using CLSI breakpoints: \u226592.9% for all antibiotics except ampicillin (87% by CLSI and EUCAST breakpoints) and trimethoprim\/sulfamethoxazole (67.4% and 72% by CLSI and EUCAST breakpoints, respectively). Susceptibility using EUCAST breakpoints (where these are published) was similar, except for cefuroxime (oral) with 3.8% of isolates susceptible. PK\/PD breakpoints indicated low susceptibility to macrolides (5.9%\u201310%) and cefaclor (13%). The application of different EUCAST breakpoints for low and higher doses for some of the antibiotics (amoxicillin, amoxicillin\/clavulanic acid, ampicillin, penicillin, ceftriaxone, clarithromycin, erythromycin, levofloxacin and trimethoprim\/sulfamethoxazole) allowed, for the first time in a SOAR study, the effect of raising the dosage on susceptibility to be quantified.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antibiotic susceptibility of S. pneumoniae was generally low, which is in keeping with evidence of inappropriate and high antibiotic use in Turkey. H. influenzae susceptibility was high. These data are important for empirical therapy of CA-RTIs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa086","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T20:33:21Z","timestamp":1584390801000},"page":"i88-i99","source":"Crossref","is-referenced-by-count":12,"title":["Results from the Survey of Antibiotic Resistance (SOAR) 2015\u201317 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints"],"prefix":"10.1093","volume":"75","author":[{"given":"D","family":"Torumkuney","sequence":"first","affiliation":[{"name":"GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tunger","sequence":"first","affiliation":[{"name":"Ege University Medical Faculty, Department of Medical Microbiology, Bornova, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Sancak","sequence":"first","affiliation":[{"name":"Hacettepe University, Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"B\u0131\u00e7ak\u00e7\u0131gil","sequence":"first","affiliation":[{"name":"Hacettepe University, Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Altun","sequence":"first","affiliation":[{"name":"Hacettepe University, Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Aktas","sequence":"first","affiliation":[{"name":"Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Kayacan","sequence":"first","affiliation":[{"name":"Istanbul Aydin University, Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Morrissey","sequence":"first","affiliation":[{"name":"IHMA Europe S\u00e0rl, Route de l\u2019Ile-au-Bois 1A, 1870 Monthey\/VS, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"2020042620061319300_dkaa086-B1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/21645515.2017.1300730","article-title":"Burden of community-acquired pneumonia in adults over 18 y of age","volume":"13","author":"Kosar","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2020042620061319300_dkaa086-B2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","article-title":"The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance","volume":"13","author":"Peyrani","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2020042620061319300_dkaa086-B3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17476348.2019.1555040","article-title":"Epidemiology of lower respiratory tract infections in adults","volume":"13","author":"Feldman","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2020042620061319300_dkaa086-B4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MCC.0000000000000550","article-title":"Community-acquired pneumonia as an emergency condition","volume":"24","author":"Cill\u00f3niz","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"2020042620061319300_dkaa086-B5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3389\/fphar.2018.01156","article-title":"Antimicrobial medicines consumption in Eastern Europe and Central Asia\u2014an updated cross-national study and assessment of quantitative metrics for policy action","volume":"9","author":"Robertson","year":"2019","journal-title":"Front Pharmacol"},{"key":"2020042620061319300_dkaa086-B6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00228-017-2229-z","article-title":"Variation of antibiotic consumption and its correlated factors in Turkey","volume":"73","author":"Sahin","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2020042620061319300_dkaa086-B7","doi-asserted-by":"crossref","first-page":"k3047","DOI":"10.1136\/bmj.k3047","article-title":"Advances in optimizing the prescription of antibiotics in outpatient settings","volume":"363","author":"King","year":"2018","journal-title":"BMJ"},{"key":"2020042620061319300_dkaa086-B8","first-page":"1429","article-title":"Assessment of rational use of drugs and self-medication in Turkey: a pilot study from Elaz\u0131g and its suburbs","volume":"29 Suppl 4","author":"Nayir","year":"2016","journal-title":"Pak J Pharm Sci"},{"key":"2020042620061319300_dkaa086-B9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2020042620061319300_dkaa086-B10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/civ1214","article-title":"Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia","volume":"62","author":"Gadsby","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020042620061319300_dkaa086-B11","first-page":"e000214","article-title":"The return of Pfeiffer\u2019s bacillus: rising incidence of ampicillin resistance in Haemophilus influenzae","volume":"4","author":"Heinz","year":"2018","journal-title":"Microb Genom"},{"key":"2020042620061319300_dkaa086-B12","year":"2018"},{"key":"2020042620061319300_dkaa086-B13","year":"2019"},{"key":"2020042620061319300_dkaa086-B14","year":"2019"},{"key":"2020042620061319300_dkaa086-B15","first-page":"1","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"130 Suppl 1","author":"Anon","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2020042620061319300_dkaa086-B16","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1093\/jac\/dkw075","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2011\u201313 in Turkey","volume":"71 Suppl 1","author":"Soyletir","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020042620061319300_dkaa086-B17","doi-asserted-by":"crossref","first-page":"i85","DOI":"10.1093\/jac\/dkw067","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey","volume":"71 Suppl 1","author":"Torumkuney","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020042620061319300_dkaa086-B18","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2016.05.043","article-title":"The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey","volume":"34","author":"Soysal","year":"2016","journal-title":"Vaccine"},{"key":"2020042620061319300_dkaa086-B19","first-page":"27","article-title":"Molecular characterization and antibiotic susceptibility of Haemophilus influenzae clinical isolates","volume":"25","author":"Kili\u00e7","year":"2017","journal-title":"Infez Med"},{"key":"2020042620061319300_dkaa086-B20","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/cc12705","article-title":"Meropenem and piperacillin\/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic\/pharmacodynamic target attainment when extended infusions are used?","volume":"17","author":"Carlier","year":"2013","journal-title":"Crit Care"},{"key":"2020042620061319300_dkaa086-B21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40262-018-0643-8","article-title":"Target-controlled continuous infusion for antibiotic dosing: proof-of-principle in an in-silico vancomycin trial in intensive care unit patients","volume":"57","author":"Colin","year":"2018","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/Supplement_1\/i88\/33121635\/dkaa086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/Supplement_1\/i88\/33121635\/dkaa086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:06:50Z","timestamp":1587946010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/Supplement_1\/i88\/5824467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":21,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,4,21]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa086","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,4,1]]}}}